Frequency News and Research

RSS
SYNTAX clinical trial results announced

SYNTAX clinical trial results announced

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

Implanet to use IBM's sensor technology for its new implant device tracking service

Implanet to use IBM's sensor technology for its new implant device tracking service

Ono Pharmaceutical secures exclusive rights to develop and commercialize asimadoline in Japan

Ono Pharmaceutical secures exclusive rights to develop and commercialize asimadoline in Japan

Primary angioplasty procedures vary in European countries

Primary angioplasty procedures vary in European countries

LINGO1 variant responsible for essential tremors and Parkinson's disease

LINGO1 variant responsible for essential tremors and Parkinson's disease

Rapid progression of multiple sclerosis linked to smoking

Rapid progression of multiple sclerosis linked to smoking

GE Healthcare to develop wireless medical monitoring systems for patient care

GE Healthcare to develop wireless medical monitoring systems for patient care

Less-invasive, organ-sparing endoscopic therapy for treating early stages of esophageal cancer

Less-invasive, organ-sparing endoscopic therapy for treating early stages of esophageal cancer

Condoms reduce risk of herpes simplex virus 2

Condoms reduce risk of herpes simplex virus 2

Children suffering from chronic headache may outgrow the condition

Children suffering from chronic headache may outgrow the condition

Ariba podcast to help pharmaceutical companies conduct cost-effective sourcing

Ariba podcast to help pharmaceutical companies conduct cost-effective sourcing

COCA to conduct meeting on ovarian cancer awareness

COCA to conduct meeting on ovarian cancer awareness

Cigarettes and not Swedish snuff increase the risk of developing multiple sclerosis

Cigarettes and not Swedish snuff increase the risk of developing multiple sclerosis

Results of the first pivotal Phase III trial with pimavanserin in patients with PDP announced

Results of the first pivotal Phase III trial with pimavanserin in patients with PDP announced

Biovail announces Phase III trial results for pimavanserin

Biovail announces Phase III trial results for pimavanserin

New clinical predictors required to determine future asthma attacks

New clinical predictors required to determine future asthma attacks

New technique developed for the treatment of cancer

New technique developed for the treatment of cancer

Merlin.net Patient Care Network launched in Europe

Merlin.net Patient Care Network launched in Europe

New intelligent reminder system with Artificial Intelligence techniques for the elderly

New intelligent reminder system with Artificial Intelligence techniques for the elderly

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.